Source: Annual Congress 2005 - Cellular and molecular mechanisms in COPD
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
E. R. Fuller, F. A. Nattress, G. M. Horne, P. J. Cook, T. Fawcett (Durham, Newcastle-upon-Tyne, United Kingdom). Cell wall deficiency: a novel mechanism for methicillin resistance in Staphylococcus aureus. Eur Respir J 2005; 26: Suppl. 49, 684

Member's Comments

No comment yet.

Related content which might interest you: Mechanisms of acquisition of resistance in Staphylococcus aureus Source: Annual Congress 2006 - Methicillin resistant Staphylococcus aureus (MRSA): a real hospital-based pathogen? Year: 2006 Treatment challenges in methicillin resistant Staphylococcus aureus infections Source: Annual Congress 2006 - Methicillin resistant Staphylococcus aureus (MRSA): a real hospital-based pathogen? Year: 2006 Staphlococcus aureus: susceptibility to antibacterial drugs and rate of MRSA Source: Eur Respir J 2006; 28: Suppl. 50, 788s Year: 2006 Evolution of tetracycline resistant S. aureus in hypoxia Source: Virtual Congress 2021 – Novel insights into the pathogenesis of chronic lung diseases Year: 2021 Predictive factors for methicillin-resistant Staphylococcus aureus (MRSA) infection in a MRSA screening protocol. Source: International Congress 2018 – Difficult-to-treat respiratory infections Year: 2018 Human airway epithelial cell response to Pseudomonas aeruginosa virulence factors preceded or not by Staphylococcus aureus Source: Eur Respir J 2006; 28: Suppl. 50, 191s Year: 2006 Stable changes in antibiotic sensitivty and cell wall structure associated with a β-lactam-induced transient cell wall-deficient phenotype in Staphylococcus aureus Source: Eur Respir J 2004; 24: Suppl. 48, 552s Year: 2004 What is MRSA? Source: Eur Respir J 2009; 34: 1190-1196 Year: 2009 The efficacies of macrolides in a murine model of methicillin-resistant staphylococcus aureus hematogenous pulmonary infection Source: Eur Respir J 2002; 20: Suppl. 38, 357s Year: 2002 Community-associated methicillin-resistant staphylococcus aureus (CA-MRSA) as a cause of hospital-acquired pneumonia (HAP) Source: Eur Respir J 2007; 30: Suppl. 51, 410s Year: 2007 Exposure to sub-lethal levels of penicillin G and high osmotic potential leads to stable antibiotic resistance in Staphylococcus aureus Source: Eur Respir J 2002; 20: Suppl. 38, 421s Year: 2002 Clinical outcomes of patients with hospital-acquired pneumonia due to community-associated methicillin resistant staphylococcus aureus (CA-MRSA) Source: Eur Respir J 2007; 30: Suppl. 51, 407s Year: 2007 Prevalence and impact on FEV1 decline of methicillin-resistant Staphylococcus aureus infection in patients with cystic fibrosis Source: Annual Congress 2011 - Cystic fibrosis: new basic, clinical and bacteriological knowledge Year: 2011 Molecular epidemiology and antimicrobial resistance of methicillin-resistant staphylococcus aureus isolated from nasal swab at intensive care unit Source: Annual Congress 2008 - Features of hospital-acquired pneumonia, ventilator-associated pneumonia and infection with other pathogens Year: 2008 Methicillin-resistant Staphylococcus aureus (MRSA) active screening in a Pulmonology department. Source: International Congress 2018 – Clinical challenges in respiratory infection Year: 2018 Staphylococcus aureus sensitivity changes to antibiotics under the influence of dissolved ozone Source: Annual Congress 2011 - Pseudomonas aeruginosa infection and non-cystic fibrosis bronchiectasis Year: 2011 Clinical implications of agr operon activity in staphylococcus aureus strains isolated from respiratory samples Source: International Congress 2015 – Respiratory infections: from basic science to clinical issues Year: 2015 Changes in susceptibility to antibiotics staphylococcus aureus under effect of dissolved ozone Source: Annual Congress 2009 - Models of chronic airways disease and therapy Year: 2009 PES (Pseudomonas , Enterobacteriaceae S. Aureus MR) a new clinical acronym to identify MDR pneumonias in the community Source: International Congress 2014 – Multidrug-resistant (MDR) pathogens that cause pneumonia Year: 2014